Heparin
Showing 26 - 50 of 2,723
Chronic Renal Failure Trial in Valinhos (Heparin sodic, heparin liquemine)
Suspended
- Chronic Renal Failure
- Heparin sodic
- heparin liquemine
-
Valinhos, Sao Paulo, BrazilLal Clinica Pesquisa E Desenvolvimento Ltda
Nov 1, 2022
Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients
Recruiting
- Heparin Overdose of Undetermined Intent
- COVID-19
- Unfractionated heparin
-
Leiden, Zuid-holland, NetherlandsLeiden University Medical Centre
Aug 19, 2022
'CTR' Ratio With Standard Haemostasis Parameters in Follow-up of
Recruiting
- Venous Thromboembolic Disease
-
Saint-Mandé, FranceHIA Bégin
Aug 7, 2023
Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)
Not yet recruiting
- Acquired Antithrombin Deficiency
- Human plasma derived antithrombin
- Placebo
- (no location specified)
Oct 17, 2023
Pregnancy Related, Antepartum DVT Trial in Los Angeles (Standard Dose of Unfractionated Heparin, Gestational Age-Based Dose of
Completed
- Pregnancy Related
- Antepartum DVT
- Standard Dose of Unfractionated Heparin
- Gestational Age-Based Dose of Unfractionated Heparin
-
Los Angeles, CaliforniaUCLA Medical Center
Jun 29, 2022
Radial Artery Occlusion Trial in Mexico City (Unfractionated Heparin)
Recruiting
- Radial Artery Occlusion
- Unfractionated Heparin
-
Mexico City, Tlalpan, MexicoInstituto Nacional de Cardiología Ignacio Chávez
Oct 14, 2022
Anticoagulation in Patients on ECMO for Severe Lung Failure
Completed
- ARDS
- COVID-19
- Argatroban Injection
- Heparin
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Sep 18, 2023
Thyroidectomy, Colon Surgery, Cholecystectomy Trial in Bursa (the medium intensity coughing technique)
Completed
- Thyroidectomy
- +3 more
- the medium intensity coughing technique
-
Bursa, Nilüfer, TurkeyBursa Uludag University Hospital
Jan 11, 2023
Interstitial Cystitis, Bladder Pain Syndrome Trial in United States (VNX001, Placebo, Lidocaine)
Not yet recruiting
- Interstitial Cystitis
- Bladder Pain Syndrome
- VNX001
- +3 more
-
Escondido, California
- +7 more
Feb 26, 2023
Cardiopulmonary Bypass Trial (Hemostasis Management System Plus, Activated Coagulation Timer System Plus)
Completed
- Cardiopulmonary Bypass
- Hemostasis Management System Plus
- Activated Coagulation Timer System Plus
-
Thessaloniki, GreeceAristotle University of Thessaloniki
Dec 29, 2022
Amputation; Traumatic, Hand Trial in Montreal (Intravenous unfractionated heparin, Sham)
Recruiting
- Amputation; Traumatic, Hand
- Intravenous unfractionated heparin
- Sham
-
Montreal, Quebec, CanadaCHUM
Aug 1, 2022
BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control
Recruiting
- Recurrent Spontaneous Abortion
- Low molecular weight heparin
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023
Heparin Binding Protein asPrognostic Biomarker of Sepsis
Completed
- Sepsis
- HBP
-
Minya, EgyptOmar Hamdy
Nov 5, 2022
Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)
Active, not recruiting
- Coronary Microvascular Dysfunction
- Bivalirudin
- standard heparin
-
Beijing, Beijing, ChinaPeking university first hospital
Aug 1, 2023
Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome Trial in Winston-Salem (Pulsed Electromagnetic Field
Not yet recruiting
- Interstitial Cystitis
- +2 more
- Pulsed Electromagnetic Field (PEMF) Device
- Sham Pulsed Electromagnetic Feild (PEMF) Device
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Aug 22, 2023
Dialysis; Complications, Heparin-induced Thrombocytopenia, Chronic Renal Failure Trial in Quincy-sous-Sénart (Hydrolink NV
Not yet recruiting
- Dialysis; Complications
- +2 more
- Hydrolink NV membrane
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Oct 17, 2022
Nursing Care Trial (Mobile-based video, Face-to-face)
Not yet recruiting
- Nursing Care
- Mobile-based video
- Face-to-face
- (no location specified)
Jul 19, 2022
Interference Between Oral Anticoagulants and Heparin During
Recruiting
- Atrial Fibrillation
- Atrial Tachycardia
-
Paris, FranceHopital Bichat-Claude Bernard
Mar 27, 2023
Critical Illness, Anticoagulation Trial (Nafamostat Mesylate, Unfractionated Heparin)
Not yet recruiting
- Critical Illness
- Anticoagulation
- Nafamostat Mesylate
- Unfractionated Heparin
- (no location specified)
Sep 23, 2022
Subcutaneous Injection Trial in Ankara (Group 1, Group 2, Group 3)
Active, not recruiting
- Subcutaneous Injection
- Group 1
- +2 more
-
Ankara, Çubuk, TurkeyAnkara Yildirim Beyazit University Faculty of Health Sciences, D
Apr 16, 2023
Compare Health Care Costs Between Apixaban and Low Molecular
Active, not recruiting
- Thromboembolism
-
New York, New YorkPfizer Investigational
Dec 1, 2022
Cardiovascular Diseases, Percutaneous Coronary Intervention Trial in Hamilton (Higher Dose UFH, Lower Dose UFH)
Recruiting
- Cardiovascular Diseases
- Percutaneous Coronary Intervention
- Higher Dose UFH
- Lower Dose UFH
-
Hamilton, Ontario, CanadaHamilton Health Sciences, General Hospital
Sep 19, 2022
Extracorporeal Membrane Oxygenation Trial in Zhengzhou (Heparin stopped before ECMO decannulation, Heparin reduced after ECMO
Recruiting
- Extracorporeal Membrane Oxygenation
- Heparin stopped before ECMO decannulation
- Heparin reduced after ECMO decannulation
-
Zhengzhou, Henan, ChinaGeneral ICU of the second affiliated hospital of zhengzhou unive
Mar 11, 2022